Do the change in β-hCG values between the 0th and 4th days in tubal ectopic pregnancy treatment with a single-dose methotrexate (MTX) protocol predict the need for a second dose of MTX?
- 26 July 2023
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 309 (6) , 2585-2590
Abstract
Aim The single-dose methotrexate (MTX) regimen is effective and minimizes side effects but an additional second dose is needed in case of failure in an ectopic pregnancy (EP). We aimed to predict the additional MTX dose by evaluating the change in β-hCG values between day 0 and day 4 in EPs with administered single-dose MTX regimen. Method A total of 454 tubal EPs between 2013 and 2019 were evaluated retrospectively. Cases cured with a single dose of MTX without an additional dose were accepted as the control group, and cases under a single-dose regimen were cured by applying a second dose of MTX on the 7th day were accepted as the study group. Obstetric and demographic characteristics and the change in β-hCG values compared in both groups. Results Age, body mass index (BMI), gravida, smoking, abdominal surgery, presence of IUDs, initial β-hCG levels (0th day), and EP size were similar in both groups, but the presence of previous EP history was significantly higher in the study group. The change of β-hCG from days 0 and 4 determined that a 20% increase predicts the need for a second dose of MTX with 72.4% sensitivity, and 87.8% negative predictive value (NPV). Conclusion The single-dose MTX protocol is successful in 83.3% of convenient cases (as the control group), but an increase of 20% in β-hCG between days 0 and 4 predicts the patients who need to be administered second-dose MTX, and thus, a double-dose MTX protocol will be achieved early.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOFEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
- Risk factors for recurrent ectopic pregnancy: a case–control studyBJOG: An International Journal of Obstetrics & Gynaecology, 2016
- Fertility after ectopic pregnancy: the DEMETER randomized trialHuman Reproduction, 2013
- Reproductive Outcomes Following Ectopic Pregnancy: Register-Based Retrospective Cohort StudyPLOS Medicine, 2012
- Ectopic pregnancy; risk factors and comparison of intervention success rates in tubal ectopic pregnancy.2011
- Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancyFertility and Sterility, 2007
- Use of “2-dose” regimen of methotrexate to treat ectopic pregnancyFertility and Sterility, 2007
- Pre- and post-treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2004
- Risk factors and clinical features of recurrent ectopic pregnancy: a case control studyFertility and Sterility, 2003
- The pharmacology of methotrexateExpert Opinion on Pharmacotherapy, 2001